Dimerix |
High $0.06 |
Low $0.06 |
Trades 18 |
Turnover $32,113 |
Volume 526,676 |
| 30 June 2023 at 3:59pm | ||||
|
Market Cap (16-Nov) $120,079,360 (1,050th) |
Close (30-Jun) $0.062 |
Volume (30-Jun) 526,676 |
Shortsold (9-Nov) 3,622 (0.00%) (625th) |
|
52w High $0.67 |
52w Low $0.158 |
P/E 10.78 |
EPS -0.05 |
COVID-19 Study Recruits Multiple Patients in Europe
DXB released this announcement to the ASX on 23 April 2021, 9:00. The announcement is marked as price sensitive, and is 3 page(s) in length and 308.13kb in size.
You can view all announcements from DXB and see how they appear on a price chart on the announcements page.
At the date of this announcement, DXB was 0.050% short sold according to ASIC data. It was ranked the 480th most shorted stock on the ASX. It remains ranked 625th as of the latest reported data (09 November 2026).
| Other Recent Announcements from DXB | |
|---|---|
| Application for quotation of securities - DXB | 29 June 2023, 9:01 |
| Application for quotation of securities - DXB | 29 June 2023, 9:00 |
| Application for quotation of securities - DXB | 29 June 2023, 8:59 |
| COVID-19 Study Recruits Multiple Patients in Europe | 23 April 2021, 9:00 |
| Notification of Expired Options | 21 April 2021, 12:21 |
| Quarterly Appendix 4C and Activities Report | 8 April 2021, 9:20 |
| Major Shareholder Loan for $5 Million | 30 March 2021, 9:01 |
If you were already registered, log in here.